Impact of Incretin Mimetics on Thyroid Cancer Among Patients with Type 2 Diabetes: A Retrospective Cohort Time-to-Event Analysis
<b>Background</b>: Incretin mimetics, including glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonist) and dipeptidyl peptidase-4 (DPP-4) inhibitors, have been increasingly utilized for glycemic control in patients with type 2 diabetes (T2D). Studies have demonstrated additio...
Saved in:
| Main Authors: | Michael W. Strand, Daniel Chow, Weining Shen, Jonathan H. Watanabe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmacoepidemiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-0618/4/2/9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CARDIOPRODUCTIVE EFFECTS OF EXXENATE AMID AND VILDAGLIPTIN INCRETIN MIMETICS IN DOXYRUBRICINE CARDIOMYOPATHY MODELING
by: A. P. TARASOVА, et al.
Published: (2017-09-01) -
New indications for exenatide therapy of type 2 diabetes mellitus
by: Olga Konstantinovna Vikulova, et al.
Published: (2010-09-01) -
Efficacy of GLP-1 analog to achieve metabolic control and correction of body weight in patients with type 2 diabetes mellitus
by: T. V. Saprina, et al.
Published: (2011-12-01) -
Mimetic set and match: Around Shaffer’s “Sleuth”
by: Andrzej Fretschel-Hojarski
Published: (2025-04-01) -
Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
by: Lubov V. Matchekhina, et al.
Published: (2017-10-01)